spacer
home > ebr > autumn 2010 >
PUBLICATIONS
European Biopharmaceutical Review


Rate this article You must be a member of the site to make a vote.  
Average rating:
1
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
News and Press Releases

MedPharms CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharms Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Readings Professor Adrian Williams have co-authored the new book: The Art and Science of Dermal Formulation Development. It is the latest addition to Drugs and the Pharmaceutical Sciences, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 
Industry Events

ELRIG Drug Discovery 2019 Looking Back to the Future

5-6 November 2019, ACC, Liverpool

Now in its 13th year, ELRIGs flagship conference Drug Discovery 2019 will take place at ACC in Liverpool. This years focus, A Look Back to the Future is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. These will be followed by cutting edge talks and examples of new directions in drug discovery. Our scientific programme will feature over 40 world-class speakers with 6 main session tracks. In partnership with key academic and charitable groups, we will also run joint disease and biology-oriented tracks focusing on the basic sciences that underpin successful drug discovery.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement